XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.2
NOTE 4 - EQUITY
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
NOTE 4 - EQUITY

NOTE 4 - EQUITY

 

All common stock numbers and exercise prices in this Note are reflected on a post reverse split (5 to 1) basis. As a result of the reverse split on February 9, 2018, the Company issued an additional 167 shares due to rounding.

 

During the nine months ended September 30, 2020, the Company recorded an option expense of $256,574 representing the amortization of the value of the options issued in 2018 that have not yet vested.

 

During the nine months ended September 30, 2019, the Company recorded an option expense of $307,703 representing the amortization of the value of the options issued in 2018 that have not yet vested. 

 

Stock Warrants and Options
Stock warrants/options outstanding and exercisable on September 30, 2020 are as follows:
 
Exercise Price per Share   Shares Under Option/warrant   Remaining Life in Years
Outstanding        
$ 0.325       3,500,000       3.33  
$ 0.15       5,220,000       2.00  
$ 0.15       580,000       0.20  
$ 0.05       200,000       2.20  
$ 0.30       200,000       2.20  
$ 0.25       5,000,000       2.92  
$ 0.24       800,000       3.92  
Exercisable                    
$ 0.325       3,500,000       3.33  
$ 0.15       5,220,000       2.00  
$ 0.15       580,000       0.20  
$ 0.05       200,000       2.20  
$ 0.30       200,000       2.00  
$ 0.25       3,500,000       2.92  
$ 0.24       800,000       2.92